Investors

By Dave Muoio 02:47 pm September 9, 2020
Bardy Diagnostics, maker of cardiac-monitoring adhesive patches, announced yesterday that Kevin Hykes began serving as the company's president and CEO on August 31. Hykes was formerly the president and CEO of Relievant Medical Systems, Metaventon and Cameron Health. Earlier in his career he spent 16 years at Medtronic. As Bardy Diagnostics' new head, he'll help develop and execute the company's...
By Laura Lovett 02:01 pm September 9, 2020
This morning, clinical-navigation platform Grand Rounds announced a whopping $175 million investment round led by the Carlyle Group. This brings the company’s total funding pot to over $270 million.  WHAT IT DOES The California-based company was founded in 2011 and started out as a second opinions site, but then pivoted to the health navigation space. Today the company makes deals with employers...
By Laura Lovett 01:11 pm September 9, 2020
Just two months after closing its Series B funding, Truepill, a digital pharmacy that focuses on APIs, telehealth practitioners and pharmacy fulfillment services, announced a new $75 million Series C funding round.  The funding, which will help kick off the company's at-home lab testing efforts, was led by Oak HC/FT with participation from Optum Ventures, TI Platform Management, Sound Ventures...
By Dave Muoio 12:28 pm September 9, 2020
Cyrus Massoumi, the cofounder and former CEO and chairman of doctor search and appointment-booking platform Zocdoc, has filed a lawsuit alleging that his fellow cofounders and the company's CFO conspired to remove him from the company through "an elaborate series of lies and deceptions." The suit, filed yesterday in New York's Supreme Court, describes a series of events leading up to a Zocdoc...
By Dave Muoio 10:48 am September 9, 2020
Oncomfort, a Belgian company using therapeutic virtual reality to relieve pain and anxiety, has raised €10 million ($11.8 million) in Series A funding. Debiopharm and Crédit Mutuel Innovation led the round, which also saw support from existing shareholders and Belgium's Walloon Region Regional Investment Company. WHAT IT DOES Oncomfort was founded in 2017, and launched its SedaKit for Digital...
By Dave Muoio 03:18 pm September 4, 2020
Connected-care-device and services company VivaLNK has partnered with healthcare engineering and tech firm Mazzetti to supply pop-up hospitals, clinics and senior centers with patient monitoring tools. These include VivaLNK's wearable vitals sensors and a connected provider platform, which the companies say will help reduce unnecessary disease exposures within these settings. “As the pandemic...
By Laura Lovett 02:27 pm September 4, 2020
Janssen, Johnson & Johnson’s pharma subsidiary, is looking to the digital health startup space for new ideas on predictive diagnostics and precision treatment. The company has launched a new nine-month startup accelerator focused on the Europe, Middle East and Africa (EMEA) region. Startups will have until Sept 27 to apply to the accelerator and must focus their pitch around ways to improve...
By Laura Lovett 01:27 pm September 3, 2020
It’s no secret that a global pandemic dialed up digital adoption. But a new study out of Accenture points out that prior to the lockdown consumer adoption of these tools had slowed, and warns that players in the digital health space must be cognizant of consumer concerns.  “While digital healthcare has accelerated, we found that the themes of our 2020 research still ring true: Consumers are...
By Dave Muoio 10:48 am September 3, 2020
Biofourmis, a Boston-based predictive-care startup that's leaning more and more into digital therapeutics, has wrapped up $100 million in Series C financing. The raise was led by SoftBank Vision Fund 2, and also saw contributions from prior backers Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. With this major jump from last May's $35 million Series B, the company is now...
By Dave Muoio 02:47 pm September 2, 2020
NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed Partners led the investment, which was joined by new backers such as Revelation Partners, Soleus Capital and an unnamed strategic investor. Prior backers KCK Group and OrbiMed Advisors also contributed. Alongside the equity, NeuroPace...